← FDA DRUG APPROVALS

FDA ANDA · ANDA090404

TRAMADOL HYDROCHLORIDE

Sponsor: SENORES PHARMS

APPLICATION
ANDA090404
TYPE
ANDA
ORIGINAL APPROVAL
2011-01-31
LATEST ACTION
2026-06-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

TRAMADOL HYDROCHLORIDEPrescription
TRAMADOL HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

2026-06-18REMS · Supplement 22AP
2025-12-31Labeling · Supplement 19 · standardAP
2025-12-31Labeling · Supplement 21 · standardAP
2024-10-31REMS · Supplement 20AP
2023-12-15Labeling · Supplement 18 · standardAP
2023-12-15Labeling · Supplement 17 · standardAP
2023-11-07Labeling · Supplement 16 · standardAP
2023-11-07Labeling · Supplement 14 · standardAP
2023-11-07Labeling · Supplement 5 · standardAP
2023-11-07Labeling · Supplement 12 · standardAP
2023-11-07Labeling · Supplement 10 · standardAP
2023-11-07Labeling · Supplement 6 · standardAP
2018-09-18REMS · Supplement 8AP
2015-11-09Labeling · Supplement 3 · standardAP
2011-01-31OriginalREMSAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →